Posted in | News

Knauf Plasterboard Tianjin Achieves Global Settlement with Homeowners

Declaration was made recently regarding a preliminary settlement between Knauf Plasterboard Tianjin and its customers, the proprietors. The company is a producer of the precarious drywall that was imported from China. Several homes were damaged on employing this tainted Chinese drywall.

Knauf Plasterboard Tianjin will reimburse over $600 M to $1 B to the affected homeowners of the country in order to repair their homes. However, the terms of the proposed preliminary settlement, anticipates receiving approval from the U.S. District Court Judge Eldon E. Fallon before being finalized.

Thousands of homes were constructed between 2004 and 2008, using the defective drywall that was produced by Knauf Plasterboard in China, according to a forecast. The defective drywall produced obnoxious and hazardous fumes and odors that corroded metals, appliances like air conditioning units and various other fixtures. As a result, many homeowners had to vacate their homes.

Terms of the proposed agreement include a remediation or repair program based on renovation, with cash settlement for alternative living expenditures, cash settlement alone will be provided for those who opt for self-remediation, a mediation program for compensation of expenses for those who already fixed their homes. In addition, recovery of equity will be offered to those who were compelled to a short sale or foreclosure. For customers who mixed drywall with another product and used Knauf as a combination product, compensation will be offered for the fraction of Knauf drywall that had been utilized. Payment of the attorneys’ fees that will benefit the proprietors, personal injury reimbursement or compensation fund will be provided for customers having suffered personal injuries.

The Court is likely to grant the preliminary settlement approval on January 4, 2012.

Source: http://www.colson.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Knauf Plasterboard Tianjin Achieves Global Settlement with Homeowners. AZoBuild. Retrieved on November 21, 2024 from https://www.azobuild.com/news.aspx?newsID=14744.

  • MLA

    Scanlon, Joel. "Knauf Plasterboard Tianjin Achieves Global Settlement with Homeowners". AZoBuild. 21 November 2024. <https://www.azobuild.com/news.aspx?newsID=14744>.

  • Chicago

    Scanlon, Joel. "Knauf Plasterboard Tianjin Achieves Global Settlement with Homeowners". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14744. (accessed November 21, 2024).

  • Harvard

    Scanlon, Joel. 2019. Knauf Plasterboard Tianjin Achieves Global Settlement with Homeowners. AZoBuild, viewed 21 November 2024, https://www.azobuild.com/news.aspx?newsID=14744.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.